 Those drugs oftentimes are safer than our current drugs. We can see that they don't have the kidney toxicity, the diabetogenicity that was described earlier. So we'll afford a better quality of life for patients. So there's no doubt the science there exists. What we need to do is couple that with the regulatory science, meaning how can we bring those forward through the FDA approval process. Mm-hmm.